Jefferies Group LLC Crispr Therapeutics Ag Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $965,201 - $1.79 Million	-28,658 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $1.05 Million - $2.1 Million	28,658 New	28,658 $1.75 Million
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $1.33 Million - $1.81 Million	-37,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $1.05 Million - $1.53 Million	37,500 New	37,500 $1.34 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.